A Vaccine Machine
Since the pandemic began, invstrs have sat patiently awaiting new developments regarding the eventual cure. It’s already been months and finally, biotech companies are on the cusp of releasing a properly researched and tested coronavirus vaccine.
The Cambridge, Massachusetts based Moderna said on Thursday that it’s been preparing for the global launch of a potential cure. They have already taken in around $1.1 billion in deposits from governments.
The company has been in ongoing talks with the World Health Organization to figure out how they plan on pricing the vaccine. It’s been said that Moderna plans on charging between $32 to $37 dollars per dose and could be priced even lower for larger volume agreements.
Interestingly, Moderna’s vaccine must be stored at minus 4 Fahrenheit. In comparison, Pfizer’s vaccine must be stored at minus 94 Fahrenheit. Yet another reason why Moderna’s vaccine or mRNA-1273 is being a top contender in the mission to rescue our world from the virus.
Moderna shares went up as high as 10% in Thursday trading.
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.